IgE signaling suppresses FcepsilonRIbeta expression

Jennifer Brenzovich1, Matthew Macey, Josephine Fernando

  • 1Department of Biology, Virginia Commonwealth University, Richmond, Virginia 23284-2012, USA.

Journal of Leukocyte Biology
|September 11, 2009
PubMed

Insights

The FcepsilonRI beta-subunit mRNA is suppressed via Fyn, Syk, PI3K, and NF-kappaB signaling. IgE and antigen cross-linkage regulate FcepsilonRI beta and beta(T) subunit expression, potentially impacting allergic disease.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • The high-affinity receptor for IgE (FcepsilonRI) is crucial in allergic responses.
  • Activation leads to receptor down-regulation via internalization and degradation.
  • Protein levels of FcepsilonRI subunits decrease after IgE cross-linking.

Purpose of the Study:

  • To investigate the regulation of FcepsilonRI beta-subunit mRNA expression.
  • To explore the coordinated regulation of FcepsilonRI subunits (beta and beta(T)) by IgE and antigen.
  • To understand the implications for allergic disease.

Main Methods:

  • Analysis of FcepsilonRI subunit mRNA and protein levels.
  • Investigating signaling pathways including Fyn, Syk, PI3K, and NF-kappaB.
  • Stimulation with IgE, antigen, IgG, calcium ionophore, and LPS.

Main Results:

  • FcepsilonRI beta-subunit mRNA is selectively suppressed through Fyn, Syk, PI3K, and NF-kappaB.
  • IgG and calcium ionophore mimicked IgE signaling in suppressing beta-subunit expression.
  • LPS did not affect beta-subunit expression.
  • IgE increased all FcepsilonRI subunits and induced beta(T).
  • The beta:beta(T) ratio decreased with IgE and reset by antigen cross-linking, mirrored at mRNA and protein levels.

Conclusions:

  • FcepsilonRI beta-subunit mRNA regulation involves specific signaling pathways.
  • IgE and FcepsilonRI signaling coordinate beta and beta(T) subunit expression.
  • This coordinated regulation may represent a homeostatic feedback loop.
  • Dysregulation of this loop could contribute to chronic inflammation and allergic diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...